Experimental cancer drug works differently than researchers originally thought
A cancer drug currently being tested in patients may have entered clinical trials based on an incorrect understanding of how it works, according to a new study led by the University of Sydney in collaboration with Goethe University, Oxford University and the Institute of Cancer Research, London.
Read original article on The Medical News →Related news
-
Unexpected link identified between rare metabolic disease gene and inherited blindness
United Kingdom
-
AI may help catch heart transplant rejection without biopsies
United Kingdom
-
Poor antibody validation wastes millions of biological samples, but solutions exist
United Kingdom
-
Blocking a nerve protein could interrupt chronic pain rather than simply mask it
United Kingdom
-
Newly identified prostate cell type may help explain why enlarged prostate develops in one region of gland
United Kingdom
-
Abortion bans make health care more expensive
United Kingdom
-
EU launches network to harness health data and AI for cardiovascular care
United Kingdom
-
C-Path and University of Arizona collaborate to investigate cellular mechanisms of Parkinson's disease in women
United Kingdom